期刊文献+

NPM1基因沉默的HL-60及其耐药细胞株的建立

Establishment of Nucleophosmin Gene Silenced HL-60 and Its Resistant Cell Line
下载PDF
导出
摘要 本研究旨在构建针对HL-60细胞及其耐药细胞株(HL-60/ADR)的NPM1-RNAi的细胞模型,为研究NPM1基因在白血病耐药过程中的作用奠定实验基础。通过针对NPM1基因的shRNA与线性化的pGCSIL-GFP载体进行连接转化,对获得的重组子(pGCSIL-GFP-NPM1-shRNA)进行PCR和测序鉴定。采用慢病毒载体系统将pHelper 1.0载体、pHelper 2.0载体与pGCSIL-GFP-NPM1-shRNA共转染293T细胞,包装成NPM1-RNAi-LV,将慢病毒载体感染HL-60及HL-60/ADR细胞。采用实时定量RT-PCR和Western blot法分别从mRNA和蛋白水平验证建立的细胞株的转染效率。结果表明,成功构建了重组真核表达载体pGCSIL-GFP-NPM1-shRNA,并通过慢病毒载体系统包装成NPM-1-RNAi-LV;将NPM1-RNAi-LV转染至HL-60及HL-60/ADR细胞后,从mRNA水平上看,对细胞的NPM1 mRNA表达有显著抑制,达到90%以上(p<0.05);从蛋白水平上看,对细胞的NPM蛋白表达具有显著的抑制效果,表明转染后的HL-60及HL-60/ADR细胞的NPM1基因特异性沉默。NPM1基因沉默后,HL-60/ADR对阿霉素的耐药性有一定程度的下降。结论:成功构建了NPM1-RNAi的HL-60及HL-60/ADR细胞模型,为进一步研究NPM1基因在白血病耐药过程中的作用建立了良好的实验基础。 This study was aimed to construct model cell line of NPM1-RNAi in HL-60 cells and its resistant line(HL-60/ADR) so as to provide a experimental basis for investigating the potential role of NPM1 gene in leukemia drug resistance.The shRNA targeting to NPM1 was ligated into linear pGCSIL-GFP vector,and transformed into E.coli DH5α.Positive clone was identified by PCR and DNA sequencing.pHelper 1.0,pHelper 2.0 and pGCSIL-GFP-NPM1-shRNA were cotransformed into 293T cells by lentivius vector system.NPM1-RNAi-LV was transfected into HL-60 and HL-60/ADR cell lines.The efficiency of NPM-RNAi-LV was detected by using real-time quantitative RT-PCR and Western blot.The results showed that the recombinant eukaryotic expression vector pGCSIL-GFP-NPM1-shRNA was constructed.pGCSIL-GFP-NPM1-shRNA was packed into NPM1-RNAi-LV by lentivirus vector system,and transfected into HL-60 and HL-60/ADR cell lines.At mRNA level,the efficiency of NPM1 mRNA knockdown was more than 90%(p〈0.05).At protein level,obvious down-regulation of NPM protein was noted,indicating that NPM1 gene in HL-60 and HL-60/ADR cell lines was knocked down after transfected with NPM1-RNAi-LV.The resistance of HL-60/ADR cell line to adriamycin decreased to a certain degree after NPM1 gene silencing.It is concluded that the model cell lines of NPM1-RNAi in HL-60 and HL-60/ADR are successfully constructed,which can be used for investigating the potential role of NPM1 gene in drug resistance of leukemia.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第6期1393-1398,共6页 Journal of Experimental Hematology
基金 国家自然科学基金(编号30572132) 福建省自然科学基金(编号C0410029) 福建医科大学基金(编号FJGXY04022) 福建省科技重点项目(编号2011Y0026)
关键词 HL-60细胞 HL-60/ADR细胞 核磷酸蛋白 RNA干扰 慢病毒载体 HL-60 cell HL-60/ADR cell nucleophosmin RNA interference lentivirus vector
  • 相关文献

参考文献16

  • 1Li J,Sejas DP,Rani R,et al.Nucleophosmin regulates cell cycleprogression and stress response in hematopoietic stem/progenitorcells.J Biol Chem,2006;281(24):16536-16545.
  • 2Okuwaki M,Matsumoto K,Tsujimoto M,et al.Function ofnucleophosmin/B23,a nucleolar acidic protein,as a histonechaperone.FEBS Lett,2001;506(3):272-276.
  • 3Grisendi S,Mecucci C,Falini B,et al.Nucleophosmin andcancer.Nat Rev Cancer,2006;6(7):493-505.
  • 4Yang YX,Hu HD,Zhang DZ,et al.Identification of proteinsresponsible for the development of adriamycin resistance in humangastric cancer cells using comparative proteomics analysis.JBiochem Mol Biol,2007;40(6):853-860.
  • 5胡建达,林敏辉,陈鑫基,刘庭波,魏天南,李静,吕联煌.应用蛋白质组学技术研究HL-60细胞及其耐阿霉素细胞株的蛋白表达差异[J].福建医科大学学报,2009,43(1):1-4. 被引量:3
  • 6Hu J,Lin M,Liu T,et al.DIGE-based proteomic analysisidentifies nucleophosmin/B23 and nucleolin C23 as over-expressedproteins in relapsed/refractory acute leukemia.Leuk Res,2011;35(8):1087-1092.
  • 7Grisendi S,Bernardi R,Rossi M,et al.Role of nucleophosmin inembryonic development and tumorigenesis.Nature,2005;437(7055):147-153.
  • 8Okuwaki M.The structure and functions of NPM1/Nucleophsmin/B23,a multifunctional nucleolar acidic protein.J Biochem.2008;143(4):441-448.
  • 9Hsu CY,Yung BY.Over-expression of nucleophosmin/B23decreases the susceptibility of human leukemia HL-60 cells toretinoic acid-induced differentiation and apoptosis.Int J Cancer.2000;88(3):392-400.
  • 10Hsu CY,Yung BY.Involvement of nucleophosmin/B23 in TPA-induced megakaryocytic differentiation of K562 cells.Br J Cancer.2003;89(7):1320-1326.

二级参考文献14

  • 1苏丽萍,王玉萍,乔振华,张丽,朱镭,鹿育晋,周永安.急性髓系白血病细胞内柔红霉素潴留与多药耐药关系的研究[J].中华血液学杂志,2005,26(8):497-498. 被引量:3
  • 2秦慧,刘霆,杨金亮,黄欣,柳斌,宋鑫,赵霞,魏于全.蛋白质组学方法筛选维甲酸耐药相关蛋白[J].中华医学杂志,2007,87(8):520-525. 被引量:8
  • 3Kourti M, Vavatsi N, Gombakls N, et al. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia[J]. Int J Hematol, 2007,86(2):166-173.
  • 4Harris M N, Ozpolat B, Abdi F, et al. Comparative proteomic analysis of alt-trans-retinoic acid treatment reveals systematic posttranseriptional control mechanisms in acute promyelocytic leukemia[J]. Blood, 2004,104(5):1314-1323.
  • 5Tonge R, Shaw J, Middleton B,et al. Validation and development of fluorescence two-dimensional differential gel electro phoresis proteomies technology[J]. Proteomics, 2001,1(3) 377-396.
  • 6Kondo T,Hirohashi S. Application of highly sensitive fluorescent dyes (CyDye DIGE fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics[J]. Nat Protoc, 2006, 1 (6) :2940-2956.
  • 7Alban A,David S O,Bjorkesten L,et al. A novel experimental design for comparative two-dimensional gel analysis., two-dimensional difference gel electrophoresis incorporating a pooled internal standard[J]. Proteomics, 2003,3 (1): 36-44.
  • 8Verrills N M,Walsh B J,Cobon G S,et al. Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel eytoskeletal alterations[J]. J Biol Chem, 2003,278(46) :45082-45093.
  • 9Rousseau B, Menard L, Haurie V, et al. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma[J]. Hepatology, 2007, 46 (4):1108-1118.
  • 10Otake Y, Sengupta T K, Bandyopadhyay S, et al. Retinoid-Induced apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of Bcl-2 mRNA[J]. Mol Pharm, 2005,67(1) 1319-326.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部